alexa
Reach Us +1-217-403-9671
Yfantopoulos J | OMICS International
ISSN 2472-1042

Pharmacoeconomics: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Yfantopoulos J

School of Economics and Political Science, University of Athens, Greece 

Biography

John Yfantopoulos is Professor of Health Economics at the University of Athens, and Ex President of the National Centre for Social Research. He received his Doctor of Philosophy in Health Economics from the University of York, York, UK. Professor Yfantopoulos has extensive teaching and research experience in Health Economics in Europe and the USA. He was the Co-Chair of the 11th European Congress of the International Society of Pharmacoeconomics and Outcome Research (ISPOR). He has conducted comparative research based on large European multicultural studies for the European Commission-Eurostat, the World Health Organization, the International Labour Office and the World Bank. He has been a member of the Standing Committee for Social Science in the European Science Foundation. ESF. In 2005 in the evaluation of the Greek research centers from an international peer review committee, he received the highest grade (excellent (5)) for his scientific work, commitment to international collaboration and research networking.

Research Interest

 Clinical pharmacy service evaluation, Cost Benefit Analysis, Cost Minimization Analysis, Cost of illness evaluation, Cost Utility Analysis, Discounting costs, Drug Code, Drug Control Authority, Health Care Delivery, Patient satisfaction, Patients's preferences, Pharmacoeconomic Evaluation, Quality of life

Global Speakers in the subject

Global Experts in the subject

Top